ELTP — Elite Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Elite Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	1.13	3.19	8.54	7.83	7.11
Net Total Accounts Receivable
Net Total Receivables	4.11	3.5	3.06	3.09	19.5
Total Inventory
Prepaid Expenses
Total Current Assets	10.3	12.2	18.9	21.5	40
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.59	6.86	6.98	10.4	14.6
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	25	26.2	35.1	40.9	83.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.64	5.81	6.69	7.83	13
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.3	10	9.93	11.9	26.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	10.7	16.2	25.2	29	57.6
Total Liabilities & Shareholders' Equity	25	26.2	35.1	40.9	83.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding